CRL · 10-Q · 2026Q3 · Full report
Capital Return Program
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 64 · Surprise 42 · In source text
The October 29, 2025 stock repurchase authorization permits up to $1.0 billion of buybacks. During the nine months ended September 26, 2026, the company repurchased 1.7 million shares for $300.0 million under the program, leaving $700.0 million authorized. Treasury stock purchases totaled $300.0 million under the program, in addition to $20.8 million of shares acquired through tax-withholding netting.
Key facts
- On October 29, 2025, the Board approved a $1.0 billion stock repurchase program; during the nine months ended September 26, 2026, the Company repurchased 1.7 million shares for $300.0 million, leaving $700.0 million authorized. source
- The Company acquired 0.1 million shares for $20.8 million through stock netting for statutory tax withholding during the nine months ended September 26, 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -4.0% | On October 29, 2025, the Board approved a $1.0 billion stock repurchase program; during the nine months ended September 26, 2026, the… |
| cash | negative | committed | -4.0% | On October 29, 2025, the Board approved a $1.0 billion stock repurchase program; during the nine months ended September 26, 2026, the… |